APO Research
Talk to an analyst

APO RESEARCH · REPORT

Scopolamine Transdermal Patch

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Scopolamine Transdermal Patch Industry Growth and Trends Forecast to 2032

29 December 202596 pages

Choose your research edition.

Industry ResearchScopolamine Transdermal Patch Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Scopolamine Transdermal Patch Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Scopolamine Transdermal Patch Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Scopolamine Transdermal Patch Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Scopolamine Transdermal Patch Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Scopolamine Transdermal Patch market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Scopolamine Transdermal Patch is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Scopolamine Transdermal Patch is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Scopolamine Transdermal Patch is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Scopolamine Transdermal Patch include Novartis, Mylan, GSK, BengbuBBCATushan Pharmaceutical Co, Perrigo and Baxter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Scopolamine Transdermal Patch market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Scopolamine Transdermal Patch market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Scopolamine Transdermal Patch market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Scopolamine Transdermal Patch.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Scopolamine Transdermal Patch market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Scopolamine Transdermal Patch Market by Company

Novartis

Mylan

GSK

BengbuBBCATushan Pharmaceutical Co

Perrigo

Baxter

Scopolamine Transdermal Patch Segment by Type

1mg

1.5mg

Scopolamine Transdermal Patch Segment by Application

Nausea/Vomiting

Parkinsonian Tremor

Motion Sickness

Others

Scopolamine Transdermal Patch Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Scopolamine Transdermal Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Scopolamine Transdermal Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Scopolamine Transdermal Patch.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Scopolamine Transdermal Patch manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Scopolamine Transdermal Patch in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 1mg Table 2. Major Company of 1.5mg Table 3. Global Scopolamine Transdermal Patch Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Scopolamine Transdermal Patch Sales by Type (2021-2026) & (K Units) Table 5. Global Scopolamine Transdermal Patch Sales Market Share in Volume by Type (2021-2026) Table 6. Global Scopolamine Transdermal Patch Sales by Type (2021-2026) & (US$ Million) Table 7. Global Scopolamine Transdermal Patch Sales Market Share in Value by Type (2021-2026) Table 8. Global Scopolamine Transdermal Patch Price by Type (2021-2026) & (US$/Unit) Table 9. Global Scopolamine Transdermal Patch Sales by Type (2027-2032) & (K Units) Table 10. Global Scopolamine Transdermal Patch Sales Market Share in Volume by Type (2027-2032) Table 11. Global Scopolamine Transdermal Patch Sales by Type (2027-2032) & (US$ Million) Table 12. Global Scopolamine Transdermal Patch Sales Market Share in Value by Type (2027-2032) Table 13. Global Scopolamine Transdermal Patch Price by Type (2027-2032) & (US$/Unit) Table 14. North America Scopolamine Transdermal Patch Sales by Type (2021-2026) & (K Units) Table 15. North America Scopolamine Transdermal Patch Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Scopolamine Transdermal Patch Sales by Type (2021-2026) & (K Units) Table 17. Europe Scopolamine Transdermal Patch Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Scopolamine Transdermal Patch Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Scopolamine Transdermal Patch Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Scopolamine Transdermal Patch Sales by Type (2021-2026) & (K Units) Table 21. Latin America Scopolamine Transdermal Patch Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Scopolamine Transdermal Patch Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Scopolamine Transdermal Patch Sales by Type (2021-2026) & (US$ Million) Table 24. Scopolamine Transdermal Patch Industry Trends Table 25. Scopolamine Transdermal Patch Industry Drivers Table 26. Scopolamine Transdermal Patch Industry Opportunities and Challenges Table 27. Scopolamine Transdermal Patch Industry Restraints Table 28. Global Scopolamine Transdermal Patch Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Scopolamine Transdermal Patch Revenue Market Share by Company (2021-2026) Table 30. Global Scopolamine Transdermal Patch Sales by Company (2021-2026) & (K Units) Table 31. Global Scopolamine Transdermal Patch Sales Share by Company (2021-2026) Table 32. Global Scopolamine Transdermal Patch Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Scopolamine Transdermal Patch Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Scopolamine Transdermal Patch Major Company Production Sites and Headquarters Table 35. Global Scopolamine Transdermal Patch Company, Product Type & Application Table 36. Global Scopolamine Transdermal Patch Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Scopolamine Transdermal Patch by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Scopolamine Transdermal Patch Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Scopolamine Transdermal Patch Sales by Region (2021-2026) & (K Units) Table 41. Global Scopolamine Transdermal Patch Sales Market Share in Volume by Region (2021-2026) Table 42. Global Scopolamine Transdermal Patch Sales by Region (2021-2026) & (US$ Million) Table 43. Global Scopolamine Transdermal Patch Sales Market Share in Value by Region (2021-2026) Table 44. Global Scopolamine Transdermal Patch Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Scopolamine Transdermal Patch Sales by Region (2027-2032) & (K Units) Table 46. Global Scopolamine Transdermal Patch Sales Market Share in Volume by Region (2027-2032) Table 47. Global Scopolamine Transdermal Patch Sales by Region (2027-2032) & (US$ Million) Table 48. Global Scopolamine Transdermal Patch Sales Market Share in Value by Region (2027-2032) Table 49. Global Scopolamine Transdermal Patch Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Scopolamine Transdermal Patch Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Scopolamine Transdermal Patch Sales by Application (2021-2026) & (K Units) Table 52. Global Scopolamine Transdermal Patch Sales Market Share in Volume by Application (2021-2026) Table 53. Global Scopolamine Transdermal Patch Sales by Application (2021-2026) & (US$ Million) Table 54. Global Scopolamine Transdermal Patch Sales Market Share in Value by Application (2021-2026) Table 55. Global Scopolamine Transdermal Patch Price by Application (2021-2026) & (US$/Unit) Table 56. Global Scopolamine Transdermal Patch Sales by Application (2027-2032) & (K Units) Table 57. Global Scopolamine Transdermal Patch Sales Market Share in Volume by Application (2027-2032) Table 58. Global Scopolamine Transdermal Patch Sales by Application (2027-2032) & (US$ Million) Table 59. Global Scopolamine Transdermal Patch Sales Market Share in Value by Application (2027-2032) Table 60. Global Scopolamine Transdermal Patch Price by Application (2027-2032) & (US$/Unit) Table 61. North America Scopolamine Transdermal Patch Sales by Application (2021-2026) & (K Units) Table 62. North America Scopolamine Transdermal Patch Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Scopolamine Transdermal Patch Sales by Application (2021-2026) & (K Units) Table 64. Europe Scopolamine Transdermal Patch Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Scopolamine Transdermal Patch Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Scopolamine Transdermal Patch Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Scopolamine Transdermal Patch Sales by Application (2021-2026) & (K Units) Table 68. Latin America Scopolamine Transdermal Patch Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Scopolamine Transdermal Patch Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Scopolamine Transdermal Patch Sales by Application (2021-2026) & (US$ Million) Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Novartis Scopolamine Transdermal Patch Product Portfolio Table 75. Novartis Recent Development Table 76. Mylan Company Information Table 77. Mylan Business Overview Table 78. Mylan Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Mylan Scopolamine Transdermal Patch Product Portfolio Table 80. Mylan Recent Development Table 81. GSK Company Information Table 82. GSK Business Overview Table 83. GSK Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. GSK Scopolamine Transdermal Patch Product Portfolio Table 85. GSK Recent Development Table 86. BengbuBBCATushan Pharmaceutical Co Company Information Table 87. BengbuBBCATushan Pharmaceutical Co Business Overview Table 88. BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Product Portfolio Table 90. BengbuBBCATushan Pharmaceutical Co Recent Development Table 91. Perrigo Company Information Table 92. Perrigo Business Overview Table 93. Perrigo Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Perrigo Scopolamine Transdermal Patch Product Portfolio Table 95. Perrigo Recent Development Table 96. Baxter Company Information Table 97. Baxter Business Overview Table 98. Baxter Scopolamine Transdermal Patch Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Baxter Scopolamine Transdermal Patch Product Portfolio Table 100. Baxter Recent Development Table 101. North America Scopolamine Transdermal Patch Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 102. North America Scopolamine Transdermal Patch Sales by Country (2021-2026) & (K Units) Table 103. North America Scopolamine Transdermal Patch Sales Market Share by Country (2021-2026) Table 104. North America Scopolamine Transdermal Patch Sales Forecast by Country (2027-2032) & (K Units) Table 105. North America Scopolamine Transdermal Patch Sales Market Share Forecast by Country (2027-2032) Table 106. North America Scopolamine Transdermal Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 107. North America Scopolamine Transdermal Patch Market Size by Country (2021-2026) & (US$ Million) Table 108. North America Scopolamine Transdermal Patch Market Share by Country (2021-2026) Table 109. North America Scopolamine Transdermal Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 110. North America Scopolamine Transdermal Patch Market Share Forecast by Country (2027-2032) Table 111. Europe Scopolamine Transdermal Patch Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. Europe Scopolamine Transdermal Patch Sales by Country (2021-2026) & (K Units) Table 113. Europe Scopolamine Transdermal Patch Sales Market Share by Country (2021-2026) Table 114. Europe Scopolamine Transdermal Patch Sales Forecast by Country (2027-2032) & (K Units) Table 115. Europe Scopolamine Transdermal Patch Sales Market Share Forecast by Country (2027-2032) Table 116. Europe Scopolamine Transdermal Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. Europe Scopolamine Transdermal Patch Market Size by Country (2021-2026) & (US$ Million) Table 118. Europe Scopolamine Transdermal Patch Market Share by Country (2021-2026) Table 119. Europe Scopolamine Transdermal Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. Europe Scopolamine Transdermal Patch Market Share Forecast by Country (2027-2032) Table 121. Asia-Pacific Scopolamine Transdermal Patch Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Asia-Pacific Scopolamine Transdermal Patch Sales by Country (2021-2026) & (K Units) Table 123. Asia-Pacific Scopolamine Transdermal Patch Sales Market Share by Country (2021-2026) Table 124. Asia-Pacific Scopolamine Transdermal Patch Sales Forecast by Country (2027-2032) & (K Units) Table 125. Asia-Pacific Scopolamine Transdermal Patch Sales Market Share Forecast by Country (2027-2032) Table 126. Asia-Pacific Scopolamine Transdermal Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Asia-Pacific Scopolamine Transdermal Patch Market Size by Country (2021-2026) & (US$ Million) Table 128. Asia-Pacific Scopolamine Transdermal Patch Market Share by Country (2021-2026) Table 129. Asia-Pacific Scopolamine Transdermal Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Asia-Pacific Scopolamine Transdermal Patch Market Share Forecast by Country (2027-2032) Table 131. Latin America Scopolamine Transdermal Patch Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Latin America Scopolamine Transdermal Patch Sales by Country (2021-2026) & (K Units) Table 133. Latin America Scopolamine Transdermal Patch Sales Market Share by Country (2021-2026) Table 134. Latin America Scopolamine Transdermal Patch Sales Forecast by Country (2027-2032) & (K Units) Table 135. Latin America Scopolamine Transdermal Patch Sales Market Share Forecast by Country (2027-2032) Table 136. Latin America Scopolamine Transdermal Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Latin America Scopolamine Transdermal Patch Market Size by Country (2021-2026) & (US$ Million) Table 138. Latin America Scopolamine Transdermal Patch Market Share by Country (2021-2026) Table 139. Latin America Scopolamine Transdermal Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Latin America Scopolamine Transdermal Patch Market Share Forecast by Country (2027-2032) Table 141. Middle East and Africa Scopolamine Transdermal Patch Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Middle East and Africa Scopolamine Transdermal Patch Sales by Country (2021-2026) & (K Units) Table 143. Middle East and Africa Scopolamine Transdermal Patch Sales Market Share by Country (2021-2026) Table 144. Middle East and Africa Scopolamine Transdermal Patch Sales Forecast by Country (2027-2032) & (K Units) Table 145. Middle East and Africa Scopolamine Transdermal Patch Sales Market Share Forecast by Country (2027-2032) Table 146. Middle East and Africa Scopolamine Transdermal Patch Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Middle East and Africa Scopolamine Transdermal Patch Market Size by Country (2021-2026) & (US$ Million) Table 148. Middle East and Africa Scopolamine Transdermal Patch Market Share by Country (2021-2026) Table 149. Middle East and Africa Scopolamine Transdermal Patch Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Middle East and Africa Scopolamine Transdermal Patch Market Share Forecast by Country (2027-2032) Table 151. Key Raw Materials Table 152. Raw Materials Key Suppliers Table 153. Scopolamine Transdermal Patch Distributors List Table 154. Scopolamine Transdermal Patch Customers List Table 155. Research Programs/Design for This Report Table 156. Authors List of This Report Table 157. Secondary Sources Table 158. Primary Sources List of Figures Figure 1. Scopolamine Transdermal Patch Image Figure 2. Global Scopolamine Transdermal Patch Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Scopolamine Transdermal Patch Market Size (2021-2032) & (US$ Million) Figure 4. Global Scopolamine Transdermal Patch Sales (2021-2032) & (K Units) Figure 5. 1mg Image Figure 6. Global 1mg Sales YoY Growth (2021-2032) & (K Units) Figure 7. 1.5mg Image Figure 8. Global 1.5mg Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Scopolamine Transdermal Patch Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Scopolamine Transdermal Patch Market Share by Type 2025 VS 2032 Figure 11. North America Scopolamine Transdermal Patch Sales Market Share in Volume by Type in 2025 Figure 12. North America Scopolamine Transdermal Patch Sales Market Share in Value by Type in 2025 Figure 13. Europe Scopolamine Transdermal Patch Sales Market Share in Volume by Type in 2025 Figure 14. Europe Scopolamine Transdermal Patch Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Scopolamine Transdermal Patch Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Scopolamine Transdermal Patch Sales Market Share in Value by Type in 2025 Figure 17. Latin America Scopolamine Transdermal Patch Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Scopolamine Transdermal Patch Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Scopolamine Transdermal Patch Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Scopolamine Transdermal Patch Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Scopolamine Transdermal Patch Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Nausea/Vomiting Image Figure 24. Global Nausea/Vomiting Sales YoY Growth (2021-2032) & (K Units) Figure 25. Parkinsonian Tremor Image Figure 26. Global Parkinsonian Tremor Sales YoY Growth (2021-2032) & (K Units) Figure 27. Motion Sickness Image Figure 28. Global Motion Sickness Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Scopolamine Transdermal Patch Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Scopolamine Transdermal Patch Market Share by Application 2025 VS 2032 Figure 33. North America Scopolamine Transdermal Patch Sales Market Share in Volume by Application in 2025 Figure 34. North America Scopolamine Transdermal Patch Sales Market Share in Value by Application in 2025 Figure 35. Europe Scopolamine Transdermal Patch Sales Market Share in Volume by Application in 2025 Figure 36. Europe Scopolamine Transdermal Patch Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Scopolamine Transdermal Patch Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Scopolamine Transdermal Patch Sales Market Share in Value by Application in 2025 Figure 39. Latin America Scopolamine Transdermal Patch Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Scopolamine Transdermal Patch Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Scopolamine Transdermal Patch Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Scopolamine Transdermal Patch Sales Market Share in Value by Application in 2025 Figure 43. North America Scopolamine Transdermal Patch Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Scopolamine Transdermal Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Scopolamine Transdermal Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Scopolamine Transdermal Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Scopolamine Transdermal Patch Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Scopolamine Transdermal Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Scopolamine Transdermal Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Scopolamine Transdermal Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Scopolamine Transdermal Patch Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Scopolamine Transdermal Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Scopolamine Transdermal Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Scopolamine Transdermal Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Scopolamine Transdermal Patch Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Scopolamine Transdermal Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Scopolamine Transdermal Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Scopolamine Transdermal Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Scopolamine Transdermal Patch Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Scopolamine Transdermal Patch Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Scopolamine Transdermal Patch Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Scopolamine Transdermal Patch Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Scopolamine Transdermal Patch Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Scopolamine Transdermal Patch Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 1mg
  • 1.5mg
Applications
  • Nausea/Vomiting
  • Parkinsonian Tremor
  • Motion Sickness
  • Others
Companies covered
  • Novartis
  • Mylan
  • GSK
  • BengbuBBCATushan Pharmaceutical Co
  • Perrigo
  • Baxter

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Scopolamine Transdermal Patch Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Scopolamine Transdermal Patch Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Scopolamine Transdermal Patch Market by Type
  6. 1.3.1 1mg
  7. 1.3.2 1.5mg
  8. 1.4 Global Scopolamine Transdermal Patch Market Size by Type
  9. 1.4.1 Global Scopolamine Transdermal Patch Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Scopolamine Transdermal Patch Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Scopolamine Transdermal Patch Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Scopolamine Transdermal Patch Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Scopolamine Transdermal Patch Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Scopolamine Transdermal Patch Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Scopolamine Transdermal Patch Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Scopolamine Transdermal Patch Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Scopolamine Transdermal Patch Industry Trends
  2. 2.2 Scopolamine Transdermal Patch Industry Drivers
  3. 2.3 Scopolamine Transdermal Patch Industry Opportunities and Challenges
  4. 2.4 Scopolamine Transdermal Patch Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Scopolamine Transdermal Patch Revenue (2021-2026)
  2. 3.2 Global Top Players by Scopolamine Transdermal Patch Sales (2021-2026)
  3. 3.3 Global Top Players by Scopolamine Transdermal Patch Price (2021-2026)
  4. 3.4 Global Scopolamine Transdermal Patch Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Scopolamine Transdermal Patch Major Company Production Sites & Headquarters
  6. 3.6 Global Scopolamine Transdermal Patch Company, Product Type & Application
  7. 3.7 Global Scopolamine Transdermal Patch Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Scopolamine Transdermal Patch Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Scopolamine Transdermal Patch Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Scopolamine Transdermal Patch Tier 1, Tier 2, and Tier 3
4 Scopolamine Transdermal Patch Regional Status and Outlook
  1. 4.1 Global Scopolamine Transdermal Patch Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Scopolamine Transdermal Patch Historic Market Size by Region
  3. 4.2.1 Global Scopolamine Transdermal Patch Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Scopolamine Transdermal Patch Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Scopolamine Transdermal Patch Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Scopolamine Transdermal Patch Forecasted Market Size by Region
  7. 4.3.1 Global Scopolamine Transdermal Patch Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Scopolamine Transdermal Patch Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Scopolamine Transdermal Patch Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Scopolamine Transdermal Patch by Application
  1. 5.1 Scopolamine Transdermal Patch Market by Application
  2. 5.1.1 Nausea/Vomiting
  3. 5.1.2 Parkinsonian Tremor
  4. 5.1.3 Motion Sickness
  5. 5.1.4 Others
  6. 5.2 Global Scopolamine Transdermal Patch Market Size by Application
  7. 5.2.1 Global Scopolamine Transdermal Patch Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Scopolamine Transdermal Patch Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Scopolamine Transdermal Patch Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Scopolamine Transdermal Patch Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Scopolamine Transdermal Patch Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Scopolamine Transdermal Patch Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Scopolamine Transdermal Patch Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Scopolamine Transdermal Patch Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Novartis
  2. 6.1.1 Novartis Company Information
  3. 6.1.2 Novartis Business Overview
  4. 6.1.3 Novartis Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Novartis Scopolamine Transdermal Patch Product Portfolio
  6. 6.1.5 Novartis Recent Developments
  7. 6.2 Mylan
  8. 6.2.1 Mylan Company Information
  9. 6.2.2 Mylan Business Overview
  10. 6.2.3 Mylan Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mylan Scopolamine Transdermal Patch Product Portfolio
  12. 6.2.5 Mylan Recent Developments
  13. 6.3 GSK
  14. 6.3.1 GSK Company Information
  15. 6.3.2 GSK Business Overview
  16. 6.3.3 GSK Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GSK Scopolamine Transdermal Patch Product Portfolio
  18. 6.3.5 GSK Recent Developments
  19. 6.4 BengbuBBCATushan Pharmaceutical Co
  20. 6.4.1 BengbuBBCATushan Pharmaceutical Co Company Information
  21. 6.4.2 BengbuBBCATushan Pharmaceutical Co Business Overview
  22. 6.4.3 BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Product Portfolio
  24. 6.4.5 BengbuBBCATushan Pharmaceutical Co Recent Developments
  25. 6.5 Perrigo
  26. 6.5.1 Perrigo Company Information
  27. 6.5.2 Perrigo Business Overview
  28. 6.5.3 Perrigo Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Perrigo Scopolamine Transdermal Patch Product Portfolio
  30. 6.5.5 Perrigo Recent Developments
  31. 6.6 Baxter
  32. 6.6.1 Baxter Company Information
  33. 6.6.2 Baxter Business Overview
  34. 6.6.3 Baxter Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Baxter Scopolamine Transdermal Patch Product Portfolio
  36. 6.6.5 Baxter Recent Developments
7 North America by Country
  1. 7.1 North America Scopolamine Transdermal Patch Sales by Country
  2. 7.1.1 North America Scopolamine Transdermal Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Scopolamine Transdermal Patch Sales by Country (2021-2026)
  4. 7.1.3 North America Scopolamine Transdermal Patch Sales Forecast by Country (2027-2032)
  5. 7.2 North America Scopolamine Transdermal Patch Market Size by Country
  6. 7.2.1 North America Scopolamine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Scopolamine Transdermal Patch Market Size by Country (2021-2026)
  8. 7.2.3 North America Scopolamine Transdermal Patch Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Scopolamine Transdermal Patch Sales by Country
  2. 8.1.1 Europe Scopolamine Transdermal Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Scopolamine Transdermal Patch Sales by Country (2021-2026)
  4. 8.1.3 Europe Scopolamine Transdermal Patch Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Scopolamine Transdermal Patch Market Size by Country
  6. 8.2.1 Europe Scopolamine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Scopolamine Transdermal Patch Market Size by Country (2021-2026)
  8. 8.2.3 Europe Scopolamine Transdermal Patch Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Scopolamine Transdermal Patch Sales by Country
  2. 9.1.1 Asia-Pacific Scopolamine Transdermal Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Scopolamine Transdermal Patch Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Scopolamine Transdermal Patch Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Scopolamine Transdermal Patch Market Size by Country
  6. 9.2.1 Asia-Pacific Scopolamine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Scopolamine Transdermal Patch Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Scopolamine Transdermal Patch Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Scopolamine Transdermal Patch Sales by Country
  2. 10.1.1 South America Scopolamine Transdermal Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Scopolamine Transdermal Patch Sales by Country (2021-2026)
  4. 10.1.3 South America Scopolamine Transdermal Patch Sales Forecast by Country (2027-2032)
  5. 10.2 South America Scopolamine Transdermal Patch Market Size by Country
  6. 10.2.1 South America Scopolamine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Scopolamine Transdermal Patch Market Size by Country (2021-2026)
  8. 10.2.3 South America Scopolamine Transdermal Patch Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Scopolamine Transdermal Patch Sales by Country
  2. 11.1.1 Middle East and Africa Scopolamine Transdermal Patch Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Scopolamine Transdermal Patch Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Scopolamine Transdermal Patch Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Scopolamine Transdermal Patch Market Size by Country
  6. 11.2.1 Middle East and Africa Scopolamine Transdermal Patch Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Scopolamine Transdermal Patch Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Scopolamine Transdermal Patch Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Scopolamine Transdermal Patch Value Chain Analysis
  2. 12.1.1 Scopolamine Transdermal Patch Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Scopolamine Transdermal Patch Production Mode & Process
  7. 12.2 Scopolamine Transdermal Patch Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Scopolamine Transdermal Patch Distributors
  10. 12.2.3 Scopolamine Transdermal Patch Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst